CE InformationCourse Progress
  • Access Webinar
  • Evaluation
  • Download PDF of Slides
  • Certificate
Evaluation

Cutaneous Lupus Erythematosus: Strategies for Diagnosis, Treatment, and Interdisciplinary Management

Evaluation

HMP Education would appreciate your feedback on the quality and impact of this activity.

Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little).

To what extent are you able to better achieve each of the following learning objectives?

Describe the clinical subtypes of CLE and strategies for accurate diagnosis
Evaluate the most recent efficacy and safety data associated with current and emerging therapies for CLE
Implement multidisciplinary, patient-centric strategies to select optimal treatment and improve the management of CLE

Please rate the faculty on the following:

Joseph Merola, MD: Knowledge, expertise, and teaching ability

Please rate the following components relating to this activity:

Content
Relevance to your practice 
Educational format 
Audience-participation portions (eg., Q&A, polling, pre/post-testing) 
Resources and/or other materials supporting the activity
Overall

Therapeutic recommendations presented in this activity did not encourage inappropriate or excessive use of products/devices.

How many patients with CLE do you see during a typical week? 

Do you feel like there were any new data presented?

Did you learn anything new?

Did you gain confidence on the new information?

Did this program include opportunities to learn as a part of a healthcare team?
Which of the following subtypes occurs in a transient nature on areas of the skin that are predominantly exposed to UV radiation or can appear as a general rash?
Which of the following agents targets ILT7 and is under investigation for CLE and DLE?
Patient-reported outcomes, such as health-related quality of life and patient global assessment of disease, should be evaluated at what point(s) during treatment?
How confident are you in your ability to implement novel treatment strategies to improve patient outcomes?
How confident are you in your ability to identify and diagnose CLE subtypes?

Do you intend to make any additional changes to your practice as a result of information gained from this activity? Please be specific.
What challenges or barriers outside of your control may prevent you from changing your practice?
255 characters max

The information presented in this activity did not serve to advance a proprietary interest of any commercial entity.
Based on my participation in this activity, I anticipate I will more often: (select all that apply)